Aigen Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,798
| Closed | -$90.7K | – | 872 |
|
|
2023
Q3 | $90.7K | Buy |
+42,798
| New | +$90.7K | 0.02% | 753 |
|
|
2023
Q2 | – | Sell |
-35,433
| Closed | -$202K | – | 819 |
|
|
2023
Q1 | $202K | Buy |
+35,433
| New | +$202K | 0.03% | 525 |
|
|
2021
Q1 | – | Sell |
-7,186
| Closed | -$653K | – | 703 |
|
|
2020
Q4 | $653K | Buy |
+7,186
| New | +$653K | 0.09% | 305 |
|